Chemomab Therapeutics (CMMB) Receivables Refunds (2017 - 2019)
Chemomab Therapeutics posted quarterly Receivables Refunds of -$433000.0 for Q3 2019, down 193.93% year-on-year from $461000.0 in Q3 2018, and down 255.2% on a QoQ basis from $279000.0 in Q2 2019.
Chemomab Therapeutics (CMMB) has 3 years of Receivables Refunds data on file, last reported at -$433000.0 in Q3 2019.
- For the quarter ending Q3 2019, Receivables Refunds fell 193.93% year-over-year to -$433000.0; the trailing twelve-month figure through Sep 2019 stood at -$433000.0 (down 193.93% YoY), and the FY2018 full-year result was $621000.0, up 92.26% from the prior year.
- Receivables Refunds for Q3 2019 stood at -$433000.0, down from $279000.0 in the prior quarter.
- Across five years, Receivables Refunds topped out at $621000.0 in Q4 2018 and bottomed at -$433000.0 in Q3 2019.
- The 3-year median for Receivables Refunds is $301000.0 (2017), against an average of $230750.0.
- Peak annual rise in Receivables Refunds reached 125.81% in 2019, while the deepest fall reached 193.93% in 2019.
- A 3-year view of Receivables Refunds shows it stood at $323000.0 in 2017, then surged by 92.26% to $621000.0 in 2018, then tumbled by 169.73% to -$433000.0 in 2019.
- The last three Receivables Refunds figures came in at -$433000.0 (Q3 2019), $279000.0 (Q2 2019), and $140000.0 (Q1 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -433,000.00 |
| Jun 30, 2019 | 279,000.00 |
| Mar 31, 2019 | 140,000.00 |
| Dec 31, 2018 | 621,000.00 |
| Sep 30, 2018 | 461,000.00 |
| Jun 30, 2018 | 393,000.00 |
| Mar 31, 2018 | 62,000.00 |
| Dec 31, 2017 | 323,000.00 |